Diabetic Foot Ulcers and Pressure Ulcers Market - Global Industry Analysis

Table Of Content

Methodology

Free Analysis

Diabetic foot ulcers have a significantly negative impact on patients and are highly prone to contamination, which can sometimes even lead to amputation. The best possible wound management treatment is essential for diabetic foot ulcers. For the most effective treatment of diabetic foot and pressure ulcers, a complete understanding of the wound, causes, risk, progression, and treatment is required by the clinicians. The high chances of recurrence of cured pressure and foot ulcers and high mortality are the key factors will boost the demand for proper treatment of diabetic foot ulcers and pressure ulcers, which, in turn, is likely to drive the global diabetic foot ulcers and pressure ulcers market over the estimated timeframe.

The global diabetic foot ulcers and pressure ulcers market is segmented based on the type of wound, treatment, and end-user. By type of wound, the global market is bifurcated into diabetic foot ulcer and pressure ulcer. The diabetic foot ulcer is further segmented into Grade 0, Grade 1, Grade 2, Grade 3, Grade 4, and Grade 5. The pressure ulcer segment is classified into Stage 1, Stage 2, Stage 3, and Stage 4. By treatment, this global market is segmented into bio-actives, wound care dressings, and wound care devices. The bio-actives segment is further segmented into growth factors, skin substitutes, and skin grafts, and other bio-actives. The wound care dressings segment is sub-segmented into foam dressings, alginate dressings, surgical debridement, film dressings, hydrocolloid dressings, and hydrogel dressings. The wound care devices segment is further divided into ultrasound therapy, negative pressure wound therapy, and others. The end-user segment includes hospitals, community health centers, home healthcare, and others.

By region, the global diabetic foot ulcers and pressure ulcers market includes Latin America, North America, Asia Pacific, Europe, and the Middle East and Africa. In 2017, North America held the major share, i.e., around 40%, of the global diabetic foot ulcers and pressure ulcers market and is anticipated dominate the market over the forecast time period as well. This can be attributed to the growing prevalence of pressure ulcers and diabetic foot ulcers, a growing number of surgical procedures, and rising geriatric population. The Asia Pacific is expected to register the highest rate of growth in the global diabetic foot ulcers and pressure ulcers market in the future.

Some key players of the global diabetic foot ulcers and pressure ulcers market are Smith & Nephew PLC, 3M Healthcare, Medline Industries, Inc., Organogenesis, Inc., BSN Medical GMBH, Acelity L.P., Molnlycke Health Care AB, ConvaTec, Inc., Coloplast A/S, and Medtronic PLC, among others.